Immune cell therapy shows promise for tough leukemia cases
NCT ID NCT05358808
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 28 times
Summary
This study tested a treatment called TCB008 for people with acute myeloid leukemia (AML) that came back or didn't respond to standard therapy. TCB008 uses donor immune cells (gamma-delta T cells) grown in a lab to attack the cancer. The trial aimed to see if these cells could reduce leukemia levels in the bone marrow and improve response rates. It included 16 adults with AML or related conditions, but the study was stopped early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bristol and Weston NHS foundation trust
Bristol, BS2 8ED, United Kingdom
-
Cardiff and Vale University LHB
Cardiff, CF14 4HH, United Kingdom
-
Guys&St Thomas NHS foundation Trust
London, SE1 7EH, United Kingdom
-
Kings College Hospital
London, SE5 9RS, United Kingdom
-
Queen Elizabeth University Hospital
Glasgow, G51 4TF, United Kingdom
-
Royal Marsden Hospital
London, SW3 6JJ, United Kingdom
Conditions
Explore the condition pages connected to this study.